Influenza Diagnostic Market Landscape 2025: Forecast Data and Growth Strategy Insights

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Influenza Diagnostic Market Through 2025?
The scale of the influenza diagnostic market has seen significant expansion in the past few years. Its size is set to rise from $2.73 billion in 2024, reaching $2.89 billion in 2025, experiencing a Compound Annual Growth Rate (CAGR) of 5.9%. The increase during the historical interval can be linked to the growth of e-commerce, labor shortages, upgrades in automation and productivity, advancements in supply chain optimization, heightened labor costs, and governmental backing for automation and robotics.

What's the Projected Size of the Global Influenza Diagnostic Market by 2029?
Over the coming years, the influenza diagnostic market is anticipated to witness robust expansion. It is projected to reach $4.01 billion by 2029, with a compound annual growth rate (CAGR) of 8.5%. The predicted growth during this period can be linked to factors such as customization and scalability, pursuit of environmental and sustainability objectives, improvement of operational efficiency, and the requirement to adapt to contemporary supply chain dynamics. Emerging trends during this forecast period encompass the incorporation of advanced technology, robotic selection and packing, autonomous mobile robots, real-time data interpretation and analytics, AI-driven decision-making processes, cooperative robots, and cutting-edge advancements in robotic tech.

View the full report here:
https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-global-market-report

Top Growth Drivers in the Influenza Diagnostic Industry: What's Accelerating the Market?
The influenza diagnostic market's growth is anticipated to be driven by the increasing usage of rapid diagnostic tests. These tests are critical medical procedures or instruments used in healthcare to conclusively confirm or dismiss the presence of a disease or condition. Their popularity is on the rise due to the ever-increasing requirement for fast and precise test results in healthcare. Specifically, Rapid influenza diagnostic tests (RIDTs), which can identify influenza viral antigens in as little as 10-15 minutes with a moderate sensitivity of 50-70%. For instance, the Australian Institute of Health and Welfare, an Australian government agency that oversees health and disease information, reported in July 2024 that the number of diagnostic imaging services climbed from 28.4 million in 2021-22 to 29.7 million in 2022-23. Consequently, rapid diagnostic tests are advancing the expansion of the influenza diagnostic market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3237&type=smp

What Trends Will Shape the Influenza Diagnostic Market Through 2029 and Beyond?
Leading firms in the influenza diagnostic market are introducing cutting-edge products like the Lucira COVID-19 & Flu Home Test for fast, simultaneous qualitative detection. The unique test kit from Lucira, which is for single-use home-based testing, can deliver results of samples collected from nasal swabs in approximately 30 minutes. In a significant development in February 2023, the US pharmaceutical giant Pfizer Inc. secured approval for the Lucira COVID-19 & Flu Home Test. This test is capable of identifying influenza A and B, more commonly known as flu, along with SARS-CoV-2, the virus responsible for COVID-19.

What Are the Main Segments in the Influenza Diagnostic Market?
The influenza diagnostic market covered in this report is segmented -

1) By Traditional diagnostic tests: Rapid influenza diagnostic tests (RIDT), Viral Culture, DFA, Serological assays, Other Traditional diagnostic tests
2) By Molecular diagnostic tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests
3) By End User: Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users

Subsegments:
1) By Rapid Influenza Diagnostic Tests (RIDT): Immunoassay-based Tests, Lateral Flow Assays, Enzyme Immunoassays (EIA)
2) By Viral Culture: Cell Culture, Egg-based Culture
3) By Direct Fluorescent Antibody (DFA) Test: Direct Fluorescent Antibody Staining
4) By Serological Assays: Hemagglutination Inhibition (HI) Assay, Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting Assay
5) By Other Traditional Diagnostic Tests: Polymerase Chain Reaction (PCR), Immunofluorescence Assays

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=3237&type=smp

Which Top Companies are Driving Growth in the Influenza Diagnostic Market?
Major companies operating in the influenza diagnostic market include F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Becton Dickinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMérieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology lnc., Analytik Jena AG, altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics Pvt Ltd., Germaine Laboratories Inc., Response Biomedical Corporation, TAUNS Laboratories Inc., TRUPCR Europe Ltd., Quest Diagnostics Inc., Labcorp Employer Services Inc., TotalWellness Ltd., Health Advocate Inc., Optum Global Solutions Private Ltd.

Which Regions Will Dominate the Influenza Diagnostic Market Through 2029?
North America was the largest region in the influenza diagnostics market in 2023. Western Europe was the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3237

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.